Cara Therapeutics | CARA - Market Capitalization


Cara Therapeutics reported $165.1M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cassava Sciences USD 96M 45M Dec/2025
Chugai Pharma JPY 13.84T 3.01T Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
J&J USD 578.59B 562M Apr/2026
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Pacira USD 1.06B 94M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
RedHill Biopharma USD 12M 17M Jun/2024
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024